479 related articles for article (PubMed ID: 26010505)
1. Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract.
Wessagowit V; Tangjaturonrusamee C; Kootiratrakarn T; Bunnag T; Pimonrat T; Muangdang N; Pichai P
Australas J Dermatol; 2016 Aug; 57(3):e76-82. PubMed ID: 26010505
[TBL] [Abstract][Full Text] [Related]
2. Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study.
Rossi A; Mari E; Scarno M; Garelli V; Maxia C; Scali E; Iorio A; Carlesimo M
Int J Immunopathol Pharmacol; 2012; 25(4):1167-73. PubMed ID: 23298508
[TBL] [Abstract][Full Text] [Related]
3. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.
Prager N; Bickett K; French N; Marcovici G
J Altern Complement Med; 2002 Apr; 8(2):143-52. PubMed ID: 12006122
[TBL] [Abstract][Full Text] [Related]
5. Hot flashes in a young girl: a wake-up call concerning Serenoa repens use in children.
Miroddi M; Carnì A; Mannucci C; Moleti M; Navarra M; Calapai G
Pediatrics; 2012 Nov; 130(5):e1374-6. PubMed ID: 23027164
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
[TBL] [Abstract][Full Text] [Related]
7. A bibliometric study of scientific literature in Scopus on botanicals for treatment of androgenetic alopecia.
Rondanelli M; Perna S; Peroni G; Guido D
J Cosmet Dermatol; 2016 Jun; 15(2):120-30. PubMed ID: 26608588
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia.
Rossi A; Campo D; Fortuna MC; Garelli V; Pranteda G; De Vita G; Sorriso-Valvo L; Di Nunno D; Carlesimo M
J Dermatolog Treat; 2018 Mar; 29(2):149-151. PubMed ID: 28604133
[TBL] [Abstract][Full Text] [Related]
9. A review of the treatment of male pattern hair loss.
York K; Meah N; Bhoyrul B; Sinclair R
Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
[No Abstract] [Full Text] [Related]
10. Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia.
Sinclair RD; Mallari RS; Tate B
Australas J Dermatol; 2002 Nov; 43(4):311-2. PubMed ID: 12423443
[TBL] [Abstract][Full Text] [Related]
11. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
12. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
Shanshanwal SJ; Dhurat RS
Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia.
Tsunemi Y; Irisawa R; Yoshiie H; Brotherton B; Ito H; Tsuboi R; Kawashima M; Manyak M;
J Dermatol; 2016 Sep; 43(9):1051-8. PubMed ID: 26893187
[TBL] [Abstract][Full Text] [Related]
14. Topical valproic acid increases the hair count in male patients with androgenetic alopecia: a randomized, comparative, clinical feasibility study using phototrichogram analysis.
Jo SJ; Shin H; Park YW; Paik SH; Park WS; Jeong YS; Shin HJ; Kwon O
J Dermatol; 2014 Apr; 41(4):285-91. PubMed ID: 24533507
[TBL] [Abstract][Full Text] [Related]
15. Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study.
Pumthong G; Asawanonda P; Varothai S; Jariyasethavong V; Triwongwaranat D; Suthipinittharm P; Ingkaninan K; Leelapornpisit P; Waranuch N
J Dermatolog Treat; 2012 Oct; 23(5):385-92. PubMed ID: 21756154
[TBL] [Abstract][Full Text] [Related]
16. Topical application of the Wnt/β-catenin activator methyl vanillate increases hair count and hair mass index in women with androgenetic alopecia.
Tosti A; Zaiac MN; Canazza A; Sanchis-Gomar F; Pareja-Galeano H; Alis R; Lucia A; Emanuele E
J Cosmet Dermatol; 2016 Dec; 15(4):469-474. PubMed ID: 27121450
[TBL] [Abstract][Full Text] [Related]
17. An overview of herbal alternatives in androgenetic alopecia.
Dhariwala MY; Ravikumar P
J Cosmet Dermatol; 2019 Aug; 18(4):966-975. PubMed ID: 30980598
[TBL] [Abstract][Full Text] [Related]
18. Improvement of androgenetic alopecia with topical Sophora flavescens Aiton extract, and identification of the two active compounds in the extract that stimulate proliferation of human hair keratinocytes.
Takahashi T; Ishino A; Arai T; Hamada C; Nakazawa Y; Iwabuchi T; Tajima M
Clin Exp Dermatol; 2016 Apr; 41(3):302-7. PubMed ID: 26453439
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
